Bioharvest Sciences Inc (BHST) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BHST Annual Cash Flow →
Looking at cash flow data from Bioharvest Sciences Inc through Dec 31 2024 provides insight into Dec 31 2025's financial flexibility across reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
12 Months
0 0 0 (Dec 31 2024)
Operating Activities
Income-11.14
Depreciation & amortization1.62
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.90
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Re Assessment Of Liability For Agricultural Research Organization-
Interest Over Agricultural Research Organization Liability-
Finance Expense Income Net-
Employee Benefits And Share Based Compensation Noncash-
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.87
Accounts Payable0.00
Increase (Decrease) in Other Accrued Liabilities0.48
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital-0.42
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-7.23
Investing Activities
Capital Expenditures2.36
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Deposit Of Restricted Cash For Bank Guarantee Net Of Drawing-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-4.71
Discontinued operations0.00
Net Cash Flow from Investing Activities-2.37
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings12.40
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock18.26
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-7.93
Proceeds From Issuing Other Equity Instruments-
Repayment Of Royalties Liability To The Agricultural Research Organization-
Exercise Of Investor Warrants By Settlement Of An Outstanding Debt-
Reclassification Of Warrants As An Equity Instrument-
Other Significant Noncash Transaction Value Of Consideration Received-
Other Significant Noncash Transaction Value Of Consideration Given-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities30.19
Effect of exchange rate on cash flow0.04
Discontinued operations0.00
Free Cash Flow-4.87
Total Cash Flow20.60
4 historic quarters locked

Sign in to unlock the full Bioharvest Sciences Inc cash flow history.

About Bioharvest Sciences Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 40-F filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001376474-26-000257

Figures are derived from filed reports and may be restated. Historical data is subject to revision.